FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...
Medscape3d
Drug-Induced Rashes in Skin of Color: Diagnostic Challenges
The risks, appearance, and consequences for drug-induced rashes often differ in patients with skin of color, further ...
Today4d
FDA expands approval of breast cancer drug Kisqali: What to know
The FDA expanded approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The decision will free up access to the medication for tens of ...
NBC New York5d
FDA expands approval of breast cancer drug Kisqali to earlier stage patients
Odum was part of the group that took Kisqali plus hormone therapy. At one point, she developed a rash over her body and had to pause treatment. Even so, she said “for me, Kisqali was something ...